Reviews in Endocrine and Metabolic Disorders

, Volume 11, Issue 4, pp 229–236 | Cite as

Fracture risk assessment in postmenopausal women



Patients with osteoporosis have an increased risk of sustaining fractures because of the low bone mineral density (BMD) and altered bone micro-architecture which are characteristic features of the disease. Although a good correlation exists between BMD and fracture risks, many other factors influence this relationship. While there is consensus that patients with osteoporosis should be investigated and treated, the issue is much less clear for patients with osteopenia. Because osteopenia is so prevalent, it would be unrealistic to treat all patients with this condition. Therefore, there is a need to identify those patients who are at risk of sustaining a fracture and would benefit most from the available therapy. Providing treatment to the appropriate risk group would not only reduce the number of fractures, but could also reduce the adverse effects associated with treatment, as treating patients earlier could shorten the treatment time. The availability of tools to select patients at risk of fracture should change the impact of the disease.


Fracture risk assessment FRAX® Osteoporosis Treatment guidelines 


  1. 1.
    NIH Consensus Development Panel. JAMA. 2001;285:785–95.CrossRefGoogle Scholar
  2. 2.
    Kanis JA, Melton LJ III, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–41.CrossRefPubMedGoogle Scholar
  3. 3.
    National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Washington DC: National Osteoporosis Foundation; 2008.Google Scholar
  4. 4.
    Kanis JA, Johnell O, Oden A. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12:989–95.CrossRefPubMedGoogle Scholar
  5. 5.
    Robbins JA, Schott AM, Garnero P, et al. Risk factors for hip fracture in women with high BMD: EPIDOS study. Osteoporos Int. 2005;16:149–54.CrossRefPubMedGoogle Scholar
  6. 6.
    Silverman S. Selecting patients for osteoporosis therapy. J Bone Miner Res. 2009;24:765–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Pluijm SM, Koes B, de Laet C, et al. A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res. 2009;24:768–74.CrossRefPubMedGoogle Scholar
  8. 8.
    Diez-Perez A, Gonzàlez-Macias J, Marin F, et al. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int. 2007;18:629–39.CrossRefPubMedGoogle Scholar
  9. 9.
    Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721–39.CrossRefPubMedGoogle Scholar
  10. 10.
    Ribot C, Temollieres F, Pouilles JM. Can we detect women with low bone mass using clinical risk factors? Am J Med. 1995;98(2A):52S–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Robbins J, Aragaki AK, Kooperberg C, et al. Factors associated with 5-year risk of hip fracture in postemenopausal women. JAMA. 2007;298:2389–98.CrossRefPubMedGoogle Scholar
  12. 12.
    Sornay-Rendu E, Munoz F, Garnero P, et al. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res. 2005;20:1813–9.CrossRefPubMedGoogle Scholar
  13. 13.
    van Staa TP, Geusens P, Kanis JA, et al. A simple clinical score for estimating the long-term risk of fracture in postmenopausal women. QJM. 2006;99:673–82.CrossRefPubMedGoogle Scholar
  14. 14.
    Kanis JA, Oden A, Johansson H, et al. FRAX and its application to clinical practice. Bone. 2009;44:732–43.CrossRefGoogle Scholar
  15. 15.
    Piirtola M, Vahlberg T, Löppönen M, et al. Fractures as predictors of excess mortality in the aged-a population-based study with a 12-year follow up. Eur J Epidemiol. 2008;23:747–55.CrossRefPubMedGoogle Scholar
  16. 16.
    Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301:513–21.CrossRefPubMedGoogle Scholar
  17. 17.
    Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22:671–85.CrossRefPubMedGoogle Scholar
  18. 18.
    Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–33.CrossRefPubMedGoogle Scholar
  19. 19.
    Cooper C, Atkinson EJ, Jacobsen SJ, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001–5.PubMedGoogle Scholar
  20. 20.
    Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003;1:78–85.CrossRefPubMedGoogle Scholar
  21. 21.
    Pande I, Scott DL, O’Neill TW, Pritchard C, et al. Quality of life, morbidity and mortality after low trauma hip fracture in men. Ann Rheum Dis. 2006;65:87–92.CrossRefPubMedGoogle Scholar
  22. 22.
    Bass E, French DD, Bradham DD, et al. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol. 2007;17:514–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Davidson CW, Merilees MJ, Wilkinson TJ, et al. Hip fracture mortality and morbidity – can we do better? N Z Med J. 2001;114:329–32.PubMedGoogle Scholar
  24. 24.
    Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320–3.CrossRefPubMedGoogle Scholar
  25. 25.
    Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195–202.CrossRefPubMedGoogle Scholar
  26. 26.
    Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–9.PubMedGoogle Scholar
  27. 27.
    Faulkner KG. Bone matters: are density increases necessary to reduce fracture risk? J Bone Miner Res. 2000;15:183–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637–45.CrossRefPubMedGoogle Scholar
  29. 29.
    Melton LJ III, Ilstrup DM, Beckenbaugh RD, et al. Hip fracture recurrence. A population-based study. Clin Orthop Relat Res. 1982;167:131–8. Clin Ortho Res 1982;167:131.PubMedGoogle Scholar
  30. 30.
    van Staa TP, Leufkens HG, Cooper C. Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int. 2002;13:624.CrossRefPubMedGoogle Scholar
  31. 31.
    Kanis JA, Johnell O, DeLaet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375–82.CrossRefPubMedGoogle Scholar
  32. 32.
    Pongchaiyakul C, Nguyen ND, Jones G, et al. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res. 2005;20:1349–55.CrossRefPubMedGoogle Scholar
  33. 33.
    Siris ES, Bilezekian JP, Rubin MR, et al. Pins and plaster aren’t enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003;88:3482–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Bahl S, Coates PS, Greenspan SL. The management of osteoporosis following hip fracture: have we improved our care? Osteoporos Int. 2003;14:884–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Cree MW, Juby AG, Carriere KC. Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int. 2003;14:722–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Lyles KW, Schenck AP, Colon-Emeric CS. Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int. 2008;19:1225–33.CrossRefPubMedGoogle Scholar
  37. 37.
    Tosi LL, Gliklich R, Kannan K, et al. The American Orthopaedic Association’s “own the bone” initiative to prevent secondary fractures. J Bone Joint Surg Am. 2008;90:163–73.CrossRefPubMedGoogle Scholar
  38. 38.
    Gregory JS, Aspden RM. Femoral geometry as a risk factor for osteoporotic hip fracture in men and women. Med Eng Phys. 2008;30:1275–86.CrossRefPubMedGoogle Scholar
  39. 39.
    Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996;11:1531–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Johnell O, Oden A, DeLaet C, et al. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int. 2002;13:523–6.CrossRefPubMedGoogle Scholar
  41. 41.
    Delmas PD, Eastell R, Garnero P, et al. Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int. 2000;11(Suppl 6):S2–17.CrossRefPubMedGoogle Scholar
  42. 42.
    DeLaet CE, Van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13:1587–93.CrossRefGoogle Scholar
  43. 43.
    DeLaet CE, Van der Klift M, Hofman A, et al. Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res. 2002;17:2231–6.CrossRefGoogle Scholar
  44. 44.
    Hochberg MC. Racial differences in bone strength. Trans Am Clin Climatol Assoc. 2007;118:305–15.PubMedGoogle Scholar
  45. 45.
    Kanis JA, Borstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporosis Int. 2005;16:581–9.CrossRefGoogle Scholar
  46. 46.
    LaFleur J, McAdam-Marx C, Kirkness C, et al. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature. Ann Pharmacother. 2008;42(3):375–86.CrossRefPubMedGoogle Scholar
  47. 47.
    DeLaet C, Kanis JA, Ogden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330–8.CrossRefGoogle Scholar
  48. 48.
    Papaioannou A, Kennedy CC, Cranney A, et al. Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int. 2009;20:507–18.CrossRefPubMedGoogle Scholar
  49. 49.
    Waugh EJ, Lam MA, Hawker GA, et al. Risk factors for low bone mass in healthy 40–60 year old women: a systematic review of the literature. Osteoporos Int. 2009;20:1–21.CrossRefPubMedGoogle Scholar
  50. 50.
    Stolee P, Poss J, Cook RJ, et al. Risk factors for hip fracture in older home care clients. J Gerontol A Biol Med Sci. 2009;64:403–10.Google Scholar
  51. 51.
    Rothem DE, Rothem L, Soudry M, et al. Nicotine modulates bone metabolism-associated gene expression in osteoblast cells [published online ahead of print May 13, 2009]. J Bone Miner Metab. 2009. Accessed May 2009.
  52. 52.
    Lim LS, Fink Ha, Kuskowski MA, et al. Osteoporotic fractures in men (MrOS) study group. Loop diuretic use and increased rates of hip bone loss in older men: the osteoporotic fractures in men study. Arch Intern Med. 2008;168:735–40.CrossRefPubMedGoogle Scholar
  53. 53.
    Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004;5(Suppl 2):S3–15.CrossRefPubMedGoogle Scholar
  54. 54.
    Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.CrossRefPubMedGoogle Scholar
  55. 55.
    Hamdy RC, Kiebzak GM. Variance in 10-year fracture irsk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom. 2009;12:158–61.CrossRefPubMedGoogle Scholar
  56. 56.
    Hamdy RC. FRAX®: a fracture risk assessment tool. Aging Health. 2009;5:489–494.Google Scholar
  57. 57.
    Borgström F, Johnell O, Kanis JA, et al. At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int. 2006;17:1459–71.CrossRefPubMedGoogle Scholar
  58. 58.
    Dawson-Hughes B, Tosteson AN, Melton LJ III, et al. National Osteoporosis Foundation Guide Committee. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19:449–58.CrossRefPubMedGoogle Scholar
  59. 59.
    Tosteson AN, Melton LJ III, Dawson-Hughes B, et al. National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19:437–47.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Quillen Chair of GeriatricsEast Tennessee State UniversityJohnson CityUSA

Personalised recommendations